IBIO iBio, Inc. - Common Stock
NASDAQ · Biotechnology · 在 SEC EDGAR 上查看 ↗ 收盘 十月 2, 2026 10-K/10-Q 八月 28, 2026
$1.13
· % 处于52周区间
· 高于低点
· 至高点
$0.7852周低点
$3.1352周高点
市值 (MRQ)
$63M
P/E (TTM)
-3.5
EPS (TTM)
$-0.32
收入 (TTM)
$100.0K
IBIO 股票快照 价格、市值、P/E、EPS、ROE、负债/权益、52周范围
价格
$1.12
市值 (MRQ)
$63M
P/E (TTM)
-3.5
EPS (TTM)
$-0.32
收入 (TTM)
$100.0K
ROE (TTM)
-65.7%
52周区间
$1–$3
IBIO 股价图表 包含技术指标的日 OHLCV — 平移、缩放和自定义您的视图
区间
条形图
柱状图粒度会根据所选周期进行调整 — 将鼠标悬停在图表上可查看柱状图的开盘价/最高价/最低价/收盘价。
股票拆分
| 除息日 | 拆股 | 类型 |
|---|---|---|
| 2023年11月29日 | 1-for-20 | 反向 |
| 2022年10月10日 | 1-for-25 | 反向 |
| 2018年6月11日 | 1-for-10 | 反向 |
10年表现 收入、净利润、利润率和每股收益趋势
收入$100.0K2020-06-30 → 2026-06-30
EPS$-0.322021-06-30 → 2026-06-30
自由现金流$-24M2021-06-30 → 2026-06-30
净利率-33044.0%2021-06-30 → 2026-06-30
估值与比率
估值 P/E、P/S、P/B、EV/EBITDA 比率 — 该股票是昂贵还是便宜？
| 指标 | 5年趋势 | IBIO | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| P/E (TTM) | -3.55年均值 ≈-5.8 | ≈-5.8 | · | · | |
| P/S (TTM) | 626.65年均值 ≈423.6 | ≈423.6 | 128.1 | 估值过高 | |
| 市净率 (MRQ) | 0.75年均值 ≈7.4 | ≈7.4 | 1.6 | 低估 | |
| 股价/自由现金流 (TTM) | -2.65年均值 ≈-7.6 | ≈-7.6 | · | · | |
| 市现率 (TTM) | -2.75年均值 ≈-8.9 | ≈-8.9 | · | · | |
| 市净率（有形资产） (MRQ) | 0.75年均值 ≈9.7 | ≈9.7 | · | · |
同行中位数按每项指标的标准化基础计算，可能与本股票显示的TTM/MRQ基础不完全匹配。
盈利能力 毛利率、营业利润率和净利率；股本回报率 (ROE)、资产回报率 (ROA)、投入资本回报率 (ROIC)
| 指标 | 5年趋势 | IBIO | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 营业利润率 (TTM) | -35141.0%5年均值 ≈-12317.4% | ≈-12317.4% | -1645.1% | 弱 | |
| EBITDA Margin (息税折旧摊销前利润率) | -35141.0%5年均值 ≈-12317.4% | ≈-12317.4% | -1645.1% | 弱 | |
| Pretax Margin (税前利润率) | -33044.0% | · | -351.7% | 弱 | |
| 净利润率 (TTM) | -33044.0%5年均值 ≈-12704.7% | ≈-12704.7% | -320.2% | 弱 | |
| ROA (TTM) | -54.0%5年均值 ≈-65.9% | ≈-65.9% | -56.6% | 持平 | |
| ROE (TTM) | -65.7%5年均值 ≈-105.3% | ≈-105.3% | -65.7% | 持平 | |
| ROIC | -41.0% | · | -40.4% | 持平 |
财务健康 债务、流动性、偿付能力 — 资产负债表强度
| 指标 | 5年趋势 | IBIO | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| 流动比率 (MRQ) | 7.95年均值 ≈3.2 | ≈3.2 | 6.1 | 流动性强 | |
| Quick Ratio (速动比率) | 4.85年均值 ≈2.2 | ≈2.2 | 4.8 | 持平 |
成长 营收、每股收益 (EPS) 和净利润增长：同比、3年复合年增长率 (CAGR)、5年复合年增长率 (CAGR)
| 指标 | 5年趋势 | IBIO | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Revenue YoY (营收同比增长) | -75.0%5年均值 ≈-5.9% | ≈-5.9% | · | · | |
| Revenue CAGR 3Y (营收3年复合年增长率) | -40.3% | · | · | · | |
| Revenue CAGR 5Y (营收5年复合年增长率) | -46.9% | · | · | · |
资本效率 资产周转率、库存周转率、应收账款周转率
| 指标 | 5年趋势 | IBIO | 5年均值 | 同行中位数 | 结论 |
|---|---|---|---|---|---|
| Asset Turnover (资产周转率) | 0.05年均值 ≈0.0 | ≈0.0 | 0.1 | 低于平均水平 | |
| Revenue / Employee (年营业收入 ÷ 员工人数（报告的 headcount，yfinance）。衍生数据 — 非存储的 SEC-XBRL 概念。) | ≈$4.3K | · | · | · |
价值 · ≈ 5年均值 · 行业中值 · 相对于中值的评判
收益历史 每股收益实际值 vs 预估值，惊喜%，达标率，下次财报日期
平均惊喜
-12.1%
下次报告
十一月 10, 2026
| 期间 | 报告 | EPS Actual | EPS 预期 | 惊喜 |
|---|---|---|---|---|
| 2026年12月31日 | 八月 28, 2026 | $-0.07 | $-0.07 | -7.7% |
| 2026年6月30日 | $-0.07 | $-0.07 | -7.7% | |
| 2026年3月31日 | $-0.06 | $-0.06 | 6.1% | |
| 2025年12月31日 | $-0.09 | $-0.08 | -6.9% | |
| 2025年9月30日 | $-0.11 | $-0.10 | -5.2% | |
| 2025年6月30日 | $-0.49 | $-0.37 | -31.6% | |
| 2025年3月31日 | $-0.49 | $-0.37 | -31.6% |
完整基本面 所有年度指标 — 损益表、资产负债表、现金流量表
损益表
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $100.0K | $400.0K | $225.0K | $0 | $2M | $2M | $2M | $2M | $444.0K | $394.0K | $948.0K | $2M | |
| Cost of Revenue | · | · | · | · | $216.0K | $1M | $703.0K | · | · | · | · | · | |
| Gross Profit | · | · | · | · | $2M | $909.0K | $935.0K | · | · | · | · | · | |
| R&D Expense | $20M | $8M | $5M | $10M | $10M | $10M | $4M | $5M | $4M | $4M | $3M | $3M | |
| SG&A Expense | $11M | $11M | $12M | $19M | $22M | $22M | $11M | $12M | $11M | $11M | $8M | $5M | |
| Operating Expenses | $35M | $19M | $17M | $29M | $32M | $32M | $15M | $18M | $15M | $15M | $11M | $9M | |
| Operating Income | $-35M | $-19M | $-17M | $-29M | $-30M | $-31M | $-14M | $-16M | $-14M | $-14M | $-10M | $-7M | |
| Interest Expense | · | · | · | $83.0K | $1M | $2M | $2M | $2M | $2M | $2M | $807.0K | $0 | |
| Interest Income | $2M | $437.0K | $363.0K | $213.0K | $177.0K | $140.0K | $15.0K | $75.0K | $15.0K | $39.0K | $22.0K | $9.0K | |
| Other Non-op | $2M | $225.0K | $1M | $32.0K | $184.0K | $8M | $-2M | $-2M | $-2M | $-2M | $-764.0K | $41.0K | |
| Pretax Income | $-33M | $-18M | · | · | · | · | · | · | · | · | · | · | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-33M | $-18M | $-25M | $-65M | $-50M | $-23M | $-16M | $-18M | $-16M | $-15M | $-10M | $-7M | |
| EPS (Basic) | $-0.32 | $-1.75 | $-6.50 | $-106.19 | $-5.78 | $-3.00 | · | · | · | · | · | · | |
| EPS (Diluted) | $-0.32 | $-1.75 | $-6.50 | $-106.19 | $-5.78 | $-3.00 | · | · | · | · | · | · | |
| Shares (Basic) | 104,060,000 | 10,499,000 | 3,831,000 | 612,000 | 8,721,000 | 7,825,000 | · | · | · | · | · | · | |
| Shares (Diluted) | 104,060,000 | 10,499,000 | 3,831,000 | 612,000 | 8,721,000 | 7,825,000 | · | · | · | · | · | · | |
| EBITDA | $-35M | $-19M | $-17M | $-29M | $-50M | $-31M | · | $-16M | $-14M | $-14M | $-10M | $-7M |
资产负债表
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $56M | $9M | $14M | $4M | $23M | $77M | $55M | $4M | $4M | $16M | $16M | $9M | |
| Receivables | · | · | $0 | $0 | $1M | $426.0K | $75.0K | $97.0K | $75.0K | $175.0K | $484.0K | $445.0K | |
| Inventory | · | · | $0 | $0 | $4M | $27.0K | · | · | · | · | · | · | |
| Prepaid Expense | $3M | $1M | $749.0K | $664.0K | $2M | $2M | $214.0K | $290.0K | $276.0K | $283.0K | $264.0K | $182.0K | |
| Other Current Assets | · | · | · | · | · | · | · | · | · | · | · | $17.0K | |
| Current Assets | $92M | $10M | $16M | $26M | $45M | $105M | $62M | $5M | $16M | $9M | $24M | $10M | |
| PP&E (Net) | $3M | $3M | $4M | $4M | $1M | $9M | $4M | $24M | $25M | $26M | $26M | $13.0K | |
| PP&E (Gross) | $5M | $5M | $5M | $5M | $1M | $10M | $4M | $29M | $28M | $27M | $26M | $40.0K | |
| Accum. Depreciation | $2M | $1M | $1M | $400.0K | $0 | $1M | $753.0K | $5M | $3M | $2M | $605.0K | $27.0K | |
| Intangibles | $2M | $7M | $5M | $5M | $5M | $952.0K | $1M | $1M | $2M | $2M | $2M | $2M | |
| Total Assets | $99M | $23M | $29M | $41M | $99M | $147M | $94M | $31M | $43M | $36M | $52M | $12M | |
| Accounts Payable | $4M | $2M | $358.0K | $2M | $4M | $2M | $2M | $1M | $790.0K | $749.0K | $1M | $1M | |
| Accrued Liabilities | $6M | $1M | $2M | $5M | $4M | $3M | $1M | $965.0K | $1M | $924.0K | $920.0K | $159.0K | |
| Short-term Debt | · | $766.0K | $218.0K | $13M | $22M | $600.0K | $261.0K | $0 | · | · | · | · | |
| Current Liabilities | $12M | $6M | $4M | $22M | $30M | $7M | $5M | $3M | $2M | $2M | $2M | $1M | |
| Capital Leases | $2M | $2M | $3M | $3M | $4M | $0 | $0 | $25M | $25M | $25M | $25M | $0 | |
| Total Liabilities | $13M | $8M | $7M | $26M | $36M | $38M | $38M | $28M | $27M | $27M | $28M | $1M | |
| Total Debt | · | $766.0K | $218.0K | $13M | $22M | $600.0K | · | · | · | · | · | · | |
| Common Stock | $56.0K | $19.0K | $9.0K | $1.0K | $9.0K | $9.0K | $140.0K | $20.0K | $16.0K | $9.0K | $89.0K | $77.0K | |
| Retained Earnings | $-365M | $-332M | $-314M | $-289M | $-224M | $-174M | $-150M | $-106M | $-88M | $-72M | $-58M | $-48M | |
| AOCI | $-45.0K | · | · | · | $-213.0K | $-63.0K | $-33.0K | $-31.0K | $-30.0K | $-29.0K | $-29.0K | $-25.0K | |
| Stockholders' Equity | $86M | $15M | $21M | $15M | $63M | $109M | $57M | $2M | $16M | $9M | $10M | $11M | |
| Liabilities + Equity | $99M | $23M | $29M | $41M | $99M | $147M | $94M | $31M | $43M | $36M | $52M | $12M | |
| Shares Outstanding | 55,698,561 | 19,349,201 | 8,623,676 | 1,015,505 | 8,727,158 | 8,714,924 | 140,071,110 | 20,152,458 | 16,040,126 | 8,911,851 | 89,109,410 | 77,205,410 |
现金流
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | · | · | · | · | · | · | · | $179.0K | · | · | · | · | |
| Stock-based Comp | $1M | $2M | $2M | $4M | $4M | $2M | $388.0K | $241.0K | $770.0K | $1M | $1M | $914.0K | |
| Deferred Tax | $-6M | $-9M | $-5M | $-13M | · | · | · | · | · | · | · | · | |
| Amort. of Intangibles | $20.0K | $20.0K | $20.0K | $126.0K | $401.0K | $291.0K | $298.0K | $322.0K | $341.0K | $350.0K | $363.0K | $358.0K | |
| Operating Cash Flow | $-23M | $-15M | $-19M | $-30M | $-37M | $-30M | $-13M | $-14M | $-13M | $-13M | $-8M | $-5M | |
| CapEx | $578.0K | $16.0K | $210.0K | $6M | $7M | $5M | $1M | $920.0K | $934.0K | $1M | $68.0K | $13.0K | |
| Investing Cash Flow | $-32M | $742.0K | $906.0K | $7M | $-5M | $-26M | $-1M | $-990.0K | $-1M | $-2M | · | · | |
| Stock Issued | $4M | $4M | $26M | $11M | · | · | · | · | · | $0 | $6M | $10M | |
| Net Stock Activity | $4M | $4M | $26M | · | · | · | · | · | · | $0 | $6M | $10M | |
| Financing Cash Flow | $103M | $9M | $24M | $2M | $-6M | $79M | $65M | $3M | $22M | $-170.0K | · | · | |
| Net Change in Cash | $48M | $-6M | $7M | $-21M | $-49M | $22M | $51M | $-12M | $8M | $-15M | $14M | $6M | |
| Free Cash Flow | $-24M | $-15M | $-19M | $-36M | $-45M | $-35M | · | $-15M | $-14M | $-14M | $-8M | $-5M |
盈利能力
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | · | · | · | · | 90.9% | 38.3% | · | · | · | · | · | · | |
| Operating Margin | -35141.0% | -4650.5% | -7392.9% | · | -2085.2% | -1312.1% | · | -782.4% | -3204.3% | -3622.8% | -1043.6% | -360.1% | |
| Net Margin | -33044.0% | -4594.2% | -11069.8% | · | -2110.9% | -978.8% | · | -871.8% | -3627.2% | -3688.3% | -1030.0% | -357.9% | |
| Pretax Margin | -33044.0% | · | · | · | · | · | · | · | · | · | · | · | |
| EBITDA Margin | -35141.0% | -4650.5% | -7392.9% | · | -2085.2% | -1312.1% | · | -782.4% | -3204.3% | -3622.8% | -1043.6% | -360.1% | |
| ROA | -54.0% | -70.8% | -71.2% | -92.5% | -40.8% | -16.0% | · | -53.1% | -43.5% | -37.9% | -19.1% | -69.8% | |
| ROE | -65.7% | -101.5% | -135.7% | -164.9% | -58.5% | -28.1% | · | -188.9% | -128.4% | -154.2% | -92.2% | -76.5% | |
| ROIC | -41.0% | · | · | · | · | · | · | · | · | · | · | · |
流动性与偿付能力
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 7.9 | 1.6 | 4.1 | 1.2 | 1.5 | 15.7 | · | 1.4 | 8.0 | 4.3 | 10.4 | · | |
| Quick Ratio | 4.8 | 1.4 | 3.7 | 0.2 | 0.8 | 11.7 | · | 1.3 | 7.9 | 4.1 | 10.3 | · | |
| Debt / Equity | · | 0.1 | 0.0 | 0.8 | 0.3 | 0.0 | · | · | · | · | · | · | |
| Interest Coverage | · | · | · | -353.5 | -35.2 | -12.7 | · | -8.3 | -7.4 | -7.4 | -12.3 | · |
效率
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | · | 0.1 | 0.0 | 0.0 | 0.0 | 0.2 | |
| Inventory Turnover | · | · | · | · | 0.1 | · | · | · | · | · | · | · | |
| Receivables Turnover | · | · | · | · | 3.3 | 9.5 | · | 23.5 | 3.6 | 1.2 | 2.0 | 5.7 |
每股
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | $1.54 | $0.77 | $2.47 | $0.76 | $7.27 | $0.50 | · | $0.12 | $1.01 | $0.10 | $0.11 | $0.15 | |
| Revenue / Share | $0.00 | $0.04 | $0.06 | $0.00 | $0.27 | · | · | · | · | · | · | · | |
| Cash Flow / Share | $-0.22 | $-1.46 | $-4.84 | $-2.49 | $-4.30 | · | · | · | · | · | · | · | |
| Cash / Share | $1.01 | $0.44 | $1.65 | $0.21 | $2.60 | $0.36 | · | $0.22 | $0.99 | $0.09 | $0.26 | $0.12 | |
| EPS (TTM) | $-0.32 | $-1.75 | $-6.50 | $-106.19 | $-5.78 | $-3.00 | · | · | · | · | · | · |
增长率
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue YoY | -75.0% | 77.8% | · | · | -20.5% | 44.8% | · | · | · | · | · | · | |
| Revenue CAGR 3Y | · | -40.3% | -54.4% | · | · | · | · | · | · | · | · | · | |
| Revenue CAGR 5Y | -46.9% | -24.6% | · | · | · | · | · | · | · | · | · | · |
估值 (TTM)
| 指标 | 趋势 | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $100.0K | $400.0K | $225.0K | $0 | $2M | $2M | $2M | $2M | $444.0K | $394.0K | $948.0K | $2M | |
| Net Income TTM | $-33M | $-18M | $-25M | $-65M | $-50M | $-23M | $-16M | $-18M | $-16M | $-15M | $-10M | $-7M | |
| Market Cap | $97M | $15M | $18M | $248M | $1.13B | $164.49B | · | $7.15B | $7.22B | $173.78B | $320.79B | $366.73B | |
| Enterprise Value | · | $7M | $4M | $256M | $1.13B | $164.42B | · | · | · | · | · | · | |
| P/E | -5.5 | -0.4 | -0.3 | -0.1 | -22.5 | -251.7 | · | · | · | · | · | · | |
| P/S | 974.7 | 36.8 | 80.9 | · | 602.2 | 69377.6 | · | 3545.2 | 16256.9 | 441068.8 | 338390.2 | 198123.0 | |
| P/B | 1.1 | 1.0 | 0.9 | 16.1 | 17.9 | 1514.9 | · | 2904.6 | 446.5 | 19495.3 | 32282.8 | 32653.0 | |
| P / Tangible Book | 1.2 | 1.8 | 1.1 | 24.8 | 19.3 | 1528.3 | 2802.7 | · | · | · | · | · | |
| P / Cash Flow | -4.2 | -1.0 | -1.0 | -8.1 | -30.3 | -5471.5 | · | -511.9 | -535.5 | -13202.2 | -39741.6 | -77613.9 | |
| P / FCF | -4.1 | -1.0 | -1.0 | -6.8 | -25.3 | -4702.0 | · | -480.3 | -500.8 | -11996.5 | -39409.6 | -77400.9 | |
| EV / EBITDA | · | -0.4 | -0.3 | -8.7 | -22.8 | -5284.9 | · | · | · | · | · | · | |
| EV / FCF | · | -0.4 | -0.2 | -7.1 | -25.3 | -4699.8 | · | · | · | · | · | · | |
| EV / Revenue | · | 17.2 | 18.7 | · | 601.9 | 69345.2 | · | · | · | · | · | · | |
| Earnings Yield | -18.3% | -230.3% | -308.1% | -870.4% | -4.5% | -0.40% | · | · | · | · | · | · |
损益表
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $100.0K | $200.0K | $0 | $200.0K | $0 | $175.0K | $0 | $0 | $50.0K | $0 | $0 | $0 | $0 | |
| R&D Expense | $9M | $3M | $4M | $4M | $3M | $2M | $2M | $1M | $1M | $904.0K | $2M | $2M | $2M | $3M | $3M | $3M | |
| SG&A Expense | $-2M | $5M | $5M | $3M | $2M | $3M | $3M | $3M | $2M | $3M | $3M | $4M | $3M | $4M | $8M | $5M | |
| Operating Expenses | $11M | $8M | $9M | $6M | $5M | $5M | $5M | $4M | $4M | $4M | $4M | $5M | $5M | $6M | $11M | $8M | |
| Operating Income | $-11M | $-8M | $-9M | $-6M | $-5M | $-5M | $-4M | $-4M | $-3M | $-4M | $-4M | $-5M | $-5M | $-6M | $-11M | $-8M | |
| Interest Expense | · | · | · | · | · | · | · | · | · | $52.0K | $34.0K | $26.0K | · | $35.0K | $31.0K | · | |
| Interest Income | $733.0K | $657.0K | $493.0K | $267.0K | $79.0K | $72.0K | $112.0K | $174.0K | $223.0K | $43.0K | $42.0K | $55.0K | $50.0K | $23.0K | $41.0K | $99.0K | |
| Other Non-op | $779.0K | $635.0K | $452.0K | $231.0K | $35.0K | $18.0K | $55.0K | $117.0K | $163.0K | $991.0K | $8.0K | $29.0K | $33.0K | $-110.0K | $10.0K | $99.0K | |
| Income Tax | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | |
| Net Income | $-11M | $-8M | $-9M | $-6M | $-5M | $-5M | $-4M | $-4M | $-8M | $-3M | $-8M | $-6M | $-6M | $-7M | $-34M | $-18M | |
| EPS (Basic) | $-0.06 | $-0.06 | $-0.09 | $-0.11 | $-0.32 | $-0.49 | $-0.48 | $-0.46 | $3.57 | $-0.85 | $-4.42 | $-4.80 | $-24.64 | $-11.07 | $-68.43 | $-2.05 | |
| EPS (Diluted) | $-0.06 | $-0.06 | $-0.09 | $-0.11 | $-0.32 | $-0.49 | $-0.48 | $-0.46 | $3.57 | $-0.85 | $-4.42 | $-4.80 | $-24.64 | $-11.07 | $-68.43 | $-2.05 | |
| Shares (Basic) | · | 119,600,000 | 99,133,000 | 52,981,000 | · | 9,862,000 | 9,132,000 | 8,633,000 | · | 3,713,000 | 1,856,000 | 1,198,000 | · | 659,000 | 490,000 | 8,842,000 | |
| Shares (Diluted) | · | 119,600,000 | 99,133,000 | 52,981,000 | · | 9,862,000 | 9,132,000 | 8,633,000 | · | 3,713,000 | 1,856,000 | 1,198,000 | · | 659,000 | 490,000 | 8,842,000 | |
| EBITDA | · | $-8M | $-9M | $-6M | · | $-5M | $-4M | $-4M | · | $-4M | $-4M | $-5M | · | $-6M | $-11M | $-8M |
资产负债表
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $56M | $48M | $29M | $28M | $9M | $5M | $7M | $11M | $14M | $5M | $3M | $1M | $4M | $7M | $4M | $10M | |
| Receivables | · | · | · | $65.0K | · | · | · | · | · | · | · | $0 | · | $70.0K | $970.0K | $1M | |
| Inventory | · | · | · | · | · | · | · | · | · | $0 | $0 | $0 | $0 | · | · | · | |
| Prepaid Expense | $3M | $2M | $670.0K | $1M | $1M | $1M | $1M | $667.0K | $749.0K | $862.0K | $894.0K | $451.0K | $664.0K | $921.0K | $414.0K | $1M | |
| Current Assets | $92M | $77M | $53M | $51M | $10M | $6M | $8M | $12M | $16M | $36M | $20M | $23M | $26M | $27M | $38M | $64M | |
| PP&E (Net) | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $4M | $3M | |
| PP&E (Gross) | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $4M | · | |
| Accum. Depreciation | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $893.0K | $729.0K | $565.0K | $400.0K | $235.0K | $115.0K | · | |
| Intangibles | $2M | $2M | $4M | $7M | $7M | $6M | $6M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $5M | $6M | |
| Total Assets | $99M | $86M | $64M | $64M | $23M | $19M | $22M | $25M | $29M | $50M | $34M | $38M | $41M | $44M | $52M | $85M | |
| Accounts Payable | $4M | $3M | $3M | $3M | $2M | $1M | $614.0K | $855.0K | $358.0K | $1M | $2M | $2M | $2M | $2M | $4M | $5M | |
| Accrued Liabilities | $6M | $2M | $2M | $850.0K | $1M | $1M | $2M | $1M | $2M | $4M | $4M | $3M | $5M | $4M | $5M | $3M | |
| Short-term Debt | · | · | · | $706.0K | $766.0K | $824.0K | $237.0K | $227.0K | $218.0K | $13M | $13M | $13M | · | $14M | $16M | $22M | |
| Current Liabilities | $12M | $7M | $6M | $6M | $6M | $5M | $5M | $3M | $4M | $21M | $22M | $21M | $22M | $22M | $28M | $32M | |
| Capital Leases | $2M | $2M | $2M | $2M | $2M | $2M | $2M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Total Liabilities | $13M | $8M | $8M | $8M | $8M | $8M | $8M | $7M | $7M | $25M | $25M | $24M | $26M | $27M | $33M | $36M | |
| Total Debt | · | · | · | $706.0K | · | $824.0K | $237.0K | $227.0K | · | $13M | $13M | $13M | · | $14M | $16M | $22M | |
| Common Stock | $56.0K | $35.0K | $30.0K | $20.0K | $19.0K | $10.0K | $9.0K | $9.0K | $9.0K | $9.0K | $30.0K | $28.0K | $1.0K | $16.0K | $12.0K | $9.0K | |
| Retained Earnings | $-365M | $-355M | $-347M | $-338M | $-332M | $-327M | $-322M | $-318M | $-314M | $-306M | $-303M | $-295M | $-289M | $-283M | $-276M | $-242M | |
| AOCI | $-45.0K | $-21.0K | $10.0K | $-15.0K | · | · | · | · | · | · | · | · | · | · | $-167.0K | $-223.0K | |
| Stockholders' Equity | $86M | $78M | $57M | $56M | $15M | $11M | $14M | $18M | $21M | $25M | $9M | $13M | $15M | $17M | $19M | $48M | |
| Liabilities + Equity | $99M | $86M | $64M | $64M | $23M | $19M | $22M | $25M | $29M | $50M | $34M | $38M | $41M | $44M | $52M | $85M | |
| Shares Outstanding | 55,698,561 | 34,543,561 | 30,053,070 | 20,254,599 | 19,349,201 | 10,066,276 | 9,167,670 | 8,637,895 | 8,623,676 | 8,517,449 | 3,243,725 | 27,653,582 | 1,015,505 | 12,368,287 | 12,368,287 | 9,006,582 |
现金流
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock-based Comp | $420.0K | $377.0K | $253.0K | $323.0K | $270.0K | $370.0K | $475.0K | $415.0K | $360.0K | $457.0K | $456.0K | $765.0K | $446.0K | $2M | $1M | $1M | |
| Amort. of Intangibles | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $5.0K | $49.0K | $67.0K | |
| Operating Cash Flow | $-6M | $-6M | $-5M | $-6M | $-5M | $-3M | $-4M | $-4M | $-5M | $-4M | $-5M | $-5M | $-5M | $-4M | $-8M | $-14M | |
| CapEx | $19.0K | $11.0K | $516.0K | $32.0K | $1.0K | $14.0K | $1.0K | $0 | $210.0K | $0 | · | · | $506.0K | $-201.0K | $3M | $2M | |
| Investing Cash Flow | $-4M | $-3M | $-3M | $-21M | $45.0K | $-14.0K | $-2.0K | $713.0K | $-144.0K | $1M | $0 | $50.0K | $-6.0K | $8M | $-1M | $29.0K | |
| Stock Issued | $0 | $3M | $0 | $219.0K | $2M | $1M | $0 | $4.0K | $14M | $4M | $4M | $3M | · | · | · | · | |
| Net Stock Activity | · | · | · | $219.0K | · | · | · | $4.0K | · | · | · | · | · | · | · | · | |
| Financing Cash Flow | $19M | $28M | $9M | $47M | $8M | $1M | $-152.0K | $-162.0K | $13M | $5M | $4M | $2M | $3M | $1M | $-3M | $1M | |
| Net Change in Cash | $9M | $19M | $561.0K | $20M | $4M | $-2M | $-4M | $-3M | $8M | $2M | $-701.0K | $-3M | $-2M | $6M | $-12M | $-13M | |
| Free Cash Flow | · | · | · | $-6M | · | · | · | · | · | · | · | · | · | · | · | $-16M |
盈利能力
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Margin | · | · | · | -5951.0% | · | · | -2209.5% | · | · | · | · | -10206.0% | · | · | · | · | |
| Net Margin | · | · | · | -5720.0% | · | · | -2182.0% | · | · | · | · | -11492.0% | · | · | · | · | |
| EBITDA Margin | · | · | · | -5951.0% | · | · | -2209.5% | · | · | · | · | -10206.0% | · | · | · | · | |
| ROA | · | -14.7% | -20.9% | -12.9% | · | -14.0% | -15.7% | -12.8% | · | -6.7% | -19.1% | -9.4% | · | -9.1% | -37.6% | -15.9% | |
| ROE | · | -17.4% | -25.5% | -15.5% | · | -26.8% | -37.8% | -25.8% | · | -15.0% | -58.6% | -18.7% | · | -15.1% | -61.3% | -24.3% |
流动性与偿付能力
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | · | 11.9 | 9.0 | 8.4 | · | 1.1 | 1.8 | 3.4 | · | 1.7 | 0.9 | 1.1 | · | 1.2 | 1.4 | 2.0 | |
| Quick Ratio | · | 7.3 | 4.9 | 4.7 | · | 0.9 | 1.5 | 3.2 | · | 0.2 | 0.1 | 0.1 | · | 0.3 | 0.2 | 0.3 | |
| Debt / Equity | · | · | · | 0.0 | · | 0.1 | 0.0 | 0.0 | · | 0.5 | 1.4 | 1.0 | · | 0.8 | 0.9 | 0.5 | |
| Interest Coverage | · | · | · | · | · | · | · | · | · | -69.7 | -132.2 | -196.3 | · | -176.3 | -341.1 | · |
效率
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | · | · | 0.0 | 0.0 | · | 0.0 | 0.0 | 0.0 | · | · | · | 0.0 | · | 0.0 | 0.0 | 0.0 | |
| Receivables Turnover | · | · | · | 3.1 | · | · | · | · | · | · | · | 0.1 | · | 0.0 | 0.0 | 0.0 |
每股
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Book Value / Share | · | $2.24 | $1.88 | $2.77 | · | $1.13 | $1.52 | $2.06 | · | $2.92 | $2.84 | $0.48 | · | $1.41 | $1.52 | $5.37 | |
| Revenue / Share | · | · | $0.00 | $0.00 | · | $0.00 | $0.02 | $0.00 | · | · | · | $0.00 | · | $0.00 | $0.00 | $0.00 | |
| Cash Flow / Share | · | · | · | $-0.11 | · | · | · | $-0.43 | · | · | · | $-0.22 | · | · | · | $-1.58 | |
| Cash / Share | · | $1.38 | $0.95 | $1.39 | · | $0.49 | $0.77 | $1.28 | · | $0.62 | $0.86 | $0.05 | · | $0.53 | $0.30 | $1.10 | |
| EPS (TTM) | · | $-0.58 | $-1.01 | $-1.40 | · | $2.14 | $1.78 | $-2.16 | · | $-34.71 | $-44.93 | $-108.94 | · | $-82.14 | $-72.49 | $-5.43 |
估值 (TTM)
| 指标 | 趋势 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | · | $300.0K | $300.0K | $500.0K | · | $375.0K | $375.0K | $175.0K | · | $50.0K | $50.0K | $50.0K | · | $0 | $2M | $2M | |
| Net Income TTM | · | $-28M | $-25M | $-20M | · | $-21M | $-19M | $-23M | · | $-23M | $-27M | $-53M | · | $-76M | $-81M | $-59M | |
| Market Cap | · | $66M | $58M | $17M | · | $40M | $22M | $19M | · | $35M | $4M | $166M | · | $515M | $109M | $766M | |
| Enterprise Value | · | · | · | $-11M | · | $36M | $16M | $8M | · | $42M | $14M | $177M | · | $522M | $121M | $778M | |
| P/E | · | -3.3 | -1.9 | -0.6 | · | 1.9 | 1.4 | -1.0 | · | -0.1 | -0.0 | -0.1 | · | -0.5 | -0.1 | -15.7 | |
| P/S | · | 218.8 | 193.3 | 33.6 | · | 107.9 | 59.9 | 109.6 | · | 691.6 | 88.9 | 3318.4 | · | · | 60.5 | 425.3 | |
| P/B | · | 0.8 | 1.0 | 0.3 | · | 3.6 | 1.6 | 1.1 | · | 1.4 | 0.5 | 12.6 | · | 29.6 | 5.8 | 15.8 | |
| P / Tangible Book | · | 0.9 | 1.1 | 0.3 | · | 7.7 | 2.9 | 1.5 | · | 1.8 | 1.2 | 21.2 | · | 42.9 | 8.1 | 18.1 | |
| P / Cash Flow | · | · | · | -3.0 | · | · | · | -5.2 | · | · | · | -31.1 | · | · | · | -54.8 | |
| EV / Revenue | · | · | · | -21.2 | · | 96.9 | 41.8 | 47.8 | · | 838.7 | 286.2 | 3541.7 | · | · | 67.3 | 432.2 | |
| Earnings Yield | · | -30.5% | -52.3% | -168.7% | · | 53.2% | 72.7% | -97.3% | · | -854.9% | -3279.6% | -1815.7% | · | -197.4% | -823.8% | -6.4% |
最近期在左侧 · 空值显示为 ·
财务报表 损益表、资产负债表、现金流量表 — 年度，近5年
| 指标 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| 收入 | $100.0K | $400.0K | $225.0K | $0 | $2M |
| 毛利率 % | · | · | · | · | 90.9% |
| 营业利润率 % | -35141.0% | -4650.5% | -7392.9% | · | -2085.2% |
| 净收入 | $-33M | $-18M | $-25M | $-65M | $-50M |
| 稀释后每股收益 (EPS) | $-0.32 | $-1.75 | $-6.50 | $-106.19 | $-5.78 |
| 指标 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| 负债/股东权益比率 | · | 0.1 | 0.0 | 0.8 | 0.3 |
| 流动比率 | 7.9 | 1.6 | 4.1 | 1.2 | 1.5 |
| 速动比率 | 4.8 | 1.4 | 3.7 | 0.2 | 0.8 |
| 指标 | 2026-06-30 | 2025-06-30 | 2024-06-30 | 2023-06-30 | 2022-06-30 |
|---|---|---|---|---|---|
| 自由现金流 | $-24M | $-15M | $-19M | $-36M | $-45M |
机构持有人 (13F) 59 家申报者 · $62.7M 总计 · 截至 2026年6月30日
在其季度SEC表格13F中报告持有此股票的机构。仅限多头头寸；单个申报人可能因单独的期权腿而出现两次。 大的抵消性看跌/看涨腿通常反映做市或对冲库存，而非方向性判断。
持有人
59
持有价值
$62.7M
新仓位
15
已退出持仓
12
机构活动 — Q2 2026 与上一季度对比
| 新仓位 | 已退出持仓 | 增加 | 减少 | 净股数变动 |
|---|---|---|---|---|
| 15 (-1 与上一季度对比) | 12 (+1 与上一季度对比) | 22 (+6 与上一季度对比) | 9 (+1 与上一季度对比) | +15.3M |
与Q1 2026对比。 SEC 13F表格的提交截止日期是季度末后45天，外加少量延迟提交的缓冲期——在此窗口期内的季度将被跳过，优先显示最近一个已完整报告的季度对。
| 机构 | 价值 | 股份 | % 已追踪的13F | 类型 |
|---|---|---|---|---|
| Affinity Asset Advisors, LLC | $7013792 | 4007881 | 11.18% | 股份 |
| Cormorant Asset Management, LP | $6247500 | 3570000 | 9.96% | 股份 |
| SILVERARC CAPITAL MANAGEMENT, LLC | $6160858 | 3520490 | 9.82% | 股份 |
| Vestal Point Capital, LP | $4550000 | 2600000 | 7.26% | 股份 |
| VANGUARD CAPITAL MANAGEMENT LLC | $3671764 | 2098151 | 5.86% | 股份 |
| Frazier Life Sciences Management, L.P. | $3418567 | 1953467 | 5.45% | 股份 |
| Ensign Peak Advisors, Inc | $3206800 | 1832457 | 5.11% | 股份 |
| Woodline Partners LP | $3108957 | 1776547 | 4.96% | 股份 |
| MILLENNIUM MANAGEMENT LLC | $2890078 | 1651473 | 4.61% | 股份 |
| CITADEL ADVISORS LLC | $2422051 | 1384029 | 3.86% | 股份 |
| Balyasny Asset Management L.P. | $2049063 | 1170893 | 3.27% | 股份 |
| BANK OF AMERICA CORP /DE/ | $1962611 | 1121492 | 3.13% | 股份 |
| VANGUARD GROUP INC | $1704478 | 883149 | 2.72% | 股份 |
| Ikarian Capital, LLC | $1674859 | 957062 | 2.67% | 股份 |
| Sio Capital Management, LLC | $1582469 | 904268 | 2.52% | 股份 |
| MARSHALL WACE, LLP | $1582233 | 904132 | 2.52% | 股份 |
| GEODE CAPITAL MANAGEMENT, LLC | $876650 | 500816 | 1.40% | 股份 |
| Walleye Capital LLC | $875656 | 500375 | 1.40% | 股份 |
| Squarepoint Ops LLC | $873026 | 498872 | 1.39% | 股份 |
| NOESIS CAPITAL MANGEMENT CORP | $708750 | 405000 | 1.13% | 股份 |
| TWO SIGMA INVESTMENTS, LP | $701167 | 400667 | 1.12% | 股份 |
| Ally Bridge Group (NY) LLC | $682757 | 390147 | 1.09% | 股份 |
| ADAR1 Capital Management, LLC | $657179 | 375531 | 1.05% | 股份 |
| Verdad Advisers, LP | $523122 | 298927 | 0.83% | 股份 |
| VANGUARD FIDUCIARY TRUST CO | $502031 | 286875 | 0.80% | 股份 |
| BOOTHBAY FUND MANAGEMENT, LLC | $445221 | 254412 | 0.71% | 股份 |
| BlackRock, Inc. | $423528 | 242016 | 0.68% | 股份 |
| RENAISSANCE TECHNOLOGIES LLC | $354982 | 202847 | 0.57% | 股份 |
| GOLDMAN SACHS GROUP INC | $350796 | 200455 | 0.56% | 股份 |
| STATE STREET CORP | $298898 | 170799 | 0.48% | 股份 |
| DAFNA Capital Management LLC | $297593 | 170053 | 0.47% | 股份 |
| TWO SIGMA ADVISERS, LP | $209212 | 108400 | 0.33% | 股份 |
| NORTHERN TRUST CORP | $194808 | 111319 | 0.31% | 股份 |
| Atom Investors LP | $177725 | 101557 | 0.28% | 股份 |
| XTX Topco Ltd | $101224 | 57842 | 0.16% | 股份 |
| Headlands Technologies LLC | $82973 | 47413 | 0.13% | 股份 |
| TWO SIGMA SECURITIES, LLC | $28264 | 16151 | 0.05% | 股份 |
| Innovative Asset Advisors Group, LLC | $26250 | 15000 | 0.04% | 股份 |
| Spark Investment Management LLC | $23625 | 13500 | 0.04% | 股份 |
| Bank of New York Mellon Corp | $18614 | 10637 | 0.03% | 股份 |
| JPMORGAN CHASE & CO | $10201 | 5897 | 0.02% | 股份 |
| Vanguard Global Advisers, LLC | $9555 | 5460 | 0.02% | 股份 |
| BARCLAYS PLC | $5696 | 3255 | 0.01% | 股份 |
| UBS Group AG | $877 | 501 | 0.00% | 股份 |
| FMR LLC | $757 | 433 | 0.00% | 股份 |
| Fortitude Family Office, LLC | $754 | 431 | 0.00% | 股份 |
| OSAIC HOLDINGS, INC. | $665 | 380 | 0.00% | 股份 |
| WELLS FARGO & COMPANY/MN | $177 | 101 | 0.00% | 股份 |
| SHP Wealth Management | $105 | 60 | 0.00% | 股份 |
| SBI Securities Co., Ltd. | $74 | 42 | 0.00% | 股份 |
激进投资者及 5%+ 股东 5 持仓
提交了 SEC Schedule 13D 的投资者 — 持有超过 5% 的受益所有权，意图影响发行人（激进股东持股、董事会活动、并购）。每一行显示该申报人持仓的最新已知状态。
| 申报人 | 已申报 | 持股 | 状态 | 目的 | 申报 |
|---|---|---|---|---|---|
| EASTERN CAPITAL LIMITED, PORTFOLIO SERVICES LTD., KENNETH B. DART ×18 申报 | 2020年8月13日 | · | 初始申报 | · | SEC |
| KENNETH B. DART ×3 申报 | 2019年3月15日 | · | 初始申报 | · | SEC |
| Carl DeSantis, DeSantis Revocable Trust, CD Financial, LLC ×3 申报 | 2014年11月18日 | · | 初始申报 | · | SEC |
| Carl DeSantis ? ? 2. ?, DeSantis Revocable Trust ? ? 2. ?, CD Financial, LLC ? ? 2. ? | 2013年9月13日 | · | 初始申报 | · | SEC |
| E. Gerald Kay, EGK, LLC ×2 申报 | 2013年6月13日 | · | 初始申报 | · | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
公司内部人士 30 位内幕人士 · 11 位高管 · 18 位董事
| 内部人士 | 角色 | 上次活动 | 持股数量 | 买入 12个月 | 卖出 12个月 | 净额 12个月 |
|---|---|---|---|---|---|---|
| Martin Brenner | Chief Executive Officer and Chief Scientific Officer | 2026年3月19日 P | 30652 | 1 | 0 | $24919 |
| Thomas Francis 3Rd Isett | CEO and Executive Chairman | 2022年9月8日 A | 1275000 | 0 | 0 | $0 |
| Felipe Duran | Chief Financial Officer | 2026年3月19日 P | 35974 | 1 | 0 | $50167 |
| James P. Mullaney | Chief Financial Officer | 2020年5月27日 M | 0 | 0 | 0 | $0 |
| Mark A Giannone | Chief Financial Officer | 2015年9月4日 A | · | 0 | 0 | $0 |
| Robert L Erwin | President | 2020年6月4日 M | 108108 | 0 | 0 | $0 |
| Randy Joe Maddux | Chief Operating Officer | 2021年12月7日 S | 271757 | 0 | 0 | $0 |
| Molly Carr | Chief Medical Officer | 2026年7月31日 A | · | 0 | 0 | $0 |
| Marc Banjak | Chief Legal Officer | 2026年3月26日 P | 25000 | 2 | 0 | $23024 |
| Robert Matthew Lutz | Chief Financial & Business Officer and Principal Accounting Officer | 2022年11月11日 A | 102165 | 0 | 0 | $0 |
| Ryan E Terence | Chief Scientific Officer | 2019年2月20日 A | · | 0 | 0 | $0 |
| Elizabeth Stoner | 董事 | 2026年5月18日 A | · | 0 | 0 | $0 |
| Antonio Bernardino Guimaraes Parada | 董事 | 2025年11月20日 A | 183823 | 0 | 0 | $0 |
| Alexandra Kropotova | 董事 | 2025年11月20日 A | · | 0 | 0 | $0 |
| Evert B. Schimmelpennink | 董事 | 2025年11月20日 A | · | 0 | 0 | $0 |
| Gary Sender | 董事 | 2025年11月20日 A | 9191 | 0 | 0 | $0 |
| William D Clark | 董事 | 2025年11月20日 A | 1838 | 0 | 0 | $0 |
| David Arkowitz | 董事 | 2025年11月20日 A | 18382 | 0 | 0 | $0 |
| Linda Washington Armstrong | 董事 | 2021年12月9日 A | · | 0 | 0 | $0 |
| Hill (Ret) James T. General | 董事 | 2021年12月9日 A | · | 0 | 0 | $0 |
| Glenn Chang | 董事 | 2021年12月9日 A | · | 0 | 0 | $0 |
| John D Mckey JR | 董事 | 2021年12月9日 A | 968284 | 0 | 0 | $0 |
| Robert Kay | 董事 | 2020年6月12日 A | · | 0 | 0 | $0 |
| Arthur Y Elliott | 董事 | 2019年4月1日 A | · | 0 | 0 | $0 |
| RUSSELL PHILIP K. | 董事 | 2019年4月1日 A | · | 0 | 0 | $0 |
| Seymour Flug | 董事 | 2019年4月1日 A | · | 0 | 0 | $0 |
| Jules A. Musing | 董事 | 2012年7月24日 A | · | 0 | 0 | $0 |
| Kenneth Bryan Dart | 10% 所有者 | 2019年3月14日 J | 1 | 0 | 0 | $0 |
| Carl Desantis | 10% 所有者 | 2014年9月17日 S | 5751143 | 0 | 0 | $0 |
| Gerald E Kay | 10% 所有者 | 2012年6月27日 S | 4119803 | 0 | 0 | $0 |
来自SEC表格3/4/5申报的内部人士；净额=仅公开市场买卖
ETF持仓 由 3 只交易所交易基金持有
权重仅反映直接股权持仓（N-PORT）；杠杆基金或基于衍生品的基金可能持有未显示的额外掉期敞口。
IBIO 分析师共识 看涨和看跌分析师观点、12个月价格目标、上涨空间
评级 · 14 位分析师
买入
中位数目标
$6.00
+433.3%
4 28.6%
强烈买入
9 64.3%
买入
1 7.1%
持有
0 0.0%
卖出
0 0.0%
强烈卖出
12个月价格目标
9 位分析师 · 2026-10-01平均目标 $5.69 +405.7%
← 低于所有目标
当前价格 $1.12
最低$4.20
平均值$5.69
最高$7.00
同行比较（GICS 子行业） 关键指标与行业同行对比
财年依据，价格截至各公司上一个财年末收盘价。
| 股票代码 | 市值 | P/E | 营收同比增长 | 净利润率 | ROE | 毛利率 |
|---|---|---|---|---|---|---|
| IBIO | $97M | -5.5 | -75.0% | -33044.0% | -65.7% | · |
| RNXT | · | -2.6 | 2511.6% | · | · | · |
| SPRO | $131M | 15.5 | 39.2% | 12.8% | 18.7% | · |
| GRML | · | · | · | · | -104.9% | · |
| RNTX | · | -0.6 | · | · | · | · |
| XBIT | · | -1.6 | · | · | · | · |
| APLM | · | -2.5 | · | -128.7% | -1305.4% | · |
| FBIO | · | · | · | · | · | · |
| NMAD | · | · | · | · | · | · |
| GOSS | $724M | -4.1 | -57.7% | -351.5% | 201.8% | · |
| INKT | · | -3.8 | 4.5% | -6931.8% | 63.4% | · |
我的指标 您的个人关注列表 — 来自完整基本面的选定行
选择对您重要的指标 — 点击上方完整基本面中任意行的 + 号。
您的选择已保存，并会跟随您浏览所有股票。
来源：SEC 10-K 于 八月 28, 2026 申报